Ambroxol (30mg/5ml) + Terbutaline (1.5mg/5ml) + Guaiphenesin (100mg/5ml)
Ultikof Expectorant is used in the treatment of cough with mucus.
100 ml in 1 bottle
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Ultikof Expectorant may be taken with or without food, but it is better to take it at a fixed time.
Ultikof Expectorant is a combination of three medicines: Ambroxol, Guaifenesin and Terbutaline, which relieves cough with mucus. Ambroxol is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out. Guaifenesin is an expectorant which decreases the stickiness of mucus (phlegm) and helps in its removal from the airways. Terbutaline is a bronchodilator. It works by relaxing the muscles in the airways and widens the airways. Together, they make breathing easier.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Ultikof Expectorant may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Ultikof Expectorant during lactation. Please consult your doctor.
It is not known whether Ultikof Expectorant alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Ultikof Expectorant should be used with caution in patients with kidney disease. Dose adjustment of Ultikof Expectorant may be needed. Please consult your doctor.
Ultikof Expectorant should be used with caution in patients with liver disease. Dose adjustment of Ultikof Expectorant may be needed. Please consult your doctor.
Limited information is available on the use of Ultikof Expectorant in these patients.
